Valuation Roche Holding AG Swiss Exchange

Equities

Real-time Estimate Cboe Europe Other stock markets 14:55:13 22/04/2026 +04			5-day change	1st Jan Change
315.95 ^CHF	-0.39%		-0.28%	-3.75%

09:27am	Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths	RE
09:27am	Roche's fenebrutinib significantly reduced relapses in RMS	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	306,810	239,812	197,073	205,191	262,098	253,501	-	-
Change	-	-21.84%	-17.82%	4.12%	27.73%	-3.28%	-	-
Enterprise Value (EV) ¹	324,977	255,396	215,772	222,528	278,258	262,661	255,919	249,519
Change	-	-21.41%	-15.51%	3.13%	25.04%	-5.61%	-2.57%	-2.5%
P/E ratio	23.4x	18.9x	17.1x	24.8x	20.5x	17x	15.8x	14.8x
PBR	13.2x	8.29x	5.91x	5.67x	7.8x	5.96x	5x	4.23x
PEG	-	-3.69x	-2.48x	-0.9x	0.4x	1.1x	1.97x	2.21x
Capitalization / Revenue	4.89x	3.79x	3.36x	3.39x	4.26x	4.04x	3.91x	3.77x
EV / Revenue	5.17x	4.04x	3.67x	3.68x	4.52x	4.19x	3.95x	3.71x
EV / EBITDA	13.2x	10.2x	9.82x	9.45x	11.3x	10.3x	9.5x	8.74x
EV / EBIT	14.8x	11.5x	11.2x	10.7x	12.7x	11.6x	10.7x	9.88x
EV / FCF	20.7x	19.6x	19.1x	14.5x	23.6x	16.6x	15.4x	13.8x
FCF Yield	4.83%	5.11%	5.23%	6.89%	4.24%	6.04%	6.51%	7.27%
Dividend per Share ²	9.3	9.5	9.6	9.7	9.8	10.01	10.29	10.53
Rate of return	2.45%	3.27%	3.93%	3.8%	2.99%	3.16%	3.24%	3.32%
EPS ²	16.2	15.37	14.31	10.31	16.04	18.63	20.12	21.47
Distribution rate	57.4%	61.8%	67.1%	94.1%	61.1%	53.7%	51.2%	49.1%
Net sales ¹	62,801	63,281	58,716	60,495	61,516	62,686	64,767	67,275
EBITDA ¹	24,692	25,015	21,976	23,538	24,608	25,467	26,943	28,564
EBIT ¹	21,897	22,173	19,240	20,823	21,833	22,562	23,915	25,262
Net income ¹	13,930	12,421	11,498	8,277	12,880	15,138	15,628	17,474
Net Debt ¹	18,167	15,584	18,699	17,337	16,160	9,160	2,418	-3,982
Reference price ²	379.10	290.50	244.50	255.50	328.20	317.20	317.20	317.20
Nbr of stocks (in thousands)	800,952	800,579	798,652	796,789	796,317	795,618	-	-
Announcement Date	03/02/22	02/02/23	01/02/24	30/01/25	29/01/26	-	-	-

¹CHF in Million²CHF

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	26.59x	10.07x	20.68x	0.75%	808B
JOHNSON & JOHNSON	24.17x	5.58x	15.18x	2.36%	545B
ABBVIE INC.	23.4x	6.19x	12.63x	3.34%	363B
ASTRAZENECA PLC	24.81x	5.13x	14.49x	1.69%	305B
NOVARTIS AG	20.63x	5.55x	13.42x	2.97%	284B
MERCK & CO., INC.	27.07x	4.67x	14.47x	3%	278B
AMGEN INC.	22.66x	6x	10.56x	2.92%	186B
NOVO NORDISK A/S	11.72x	4.24x	8.87x	4.42%	172B
GILEAD SCIENCES, INC.	18.1x	5.66x	10.43x	2.47%	165B
Average	22.13x	5.90x	13.42x	2.66%	345.16B
Weighted average by Cap.	23.60x	6.64x	15.14x	2.26%